alpha-aminopyridine has been researched along with Hypoxia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (56.25) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Busquet, N; Diaz, MJ; Gonzalez, MI; Lam, PM; Laoprasert, M; Raol, YH; Sampath, D; White, AM | 1 |
| Chen, W; Jin, D; Li, G; Shi, Y; Zhang, Y; Zhou, H | 1 |
| Azab, AK; Azab, F; Buggio, M; de la Puente, P; Fiala, M; Muz, B; Pachter, JA; Padval, MV; Vij, R; Weaver, DT | 1 |
| Brennan, S; Ghaly, Y; Gurney, AM; Herget, J; Joshi, S; Mizera, R; Novotna, J; Sedivy, V; Zaloudikova, M | 1 |
| Raol, YH; Sampath, D; Shmueli, D; White, AM | 1 |
| Adnot, S; Eddahibi, S; Hatzelmann, A; Izikki, M; Klar, J; Marx, D; Raffestin, B; Tenor, H; Zadigue, P | 1 |
| Gurney, AM; MacLean, MR; Morecroft, I; Murray, A; Nilsen, M | 1 |
| Gibson, GE; Pelmas, CJ; Peterson, C | 1 |
| Lahiri, S; Pokorski, M | 1 |
| Gibson, GE; Peterson, C | 2 |
| McMurtry, IF | 1 |
| Einzig, S; Kulik, TJ; Lock, JE; Mammel, MC; Thompson, TR | 1 |
| Krnjevic, K; Leblond, J | 1 |
| Freeman, GB; Gibson, GE; Mykytyn, V | 1 |
| Brutsaert, DL; Chalant, CH; Goenen, MJ; Sys, SU | 1 |
16 other study(ies) available for alpha-aminopyridine and Hypoxia
| Article | Year |
|---|---|
Effects of a potassium channel opener on brain injury and neurologic outcomes in an animal model of neonatal hypoxic-ischemic injury.
Topics: Aminopyridines; Animals; Animals, Newborn; Anticonvulsants; Brain; Brain Injuries; Carotid Arteries; Cognition; Disease Models, Animal; Hand Strength; Hypoxia; Hypoxia-Ischemia, Brain; Male; Maze Learning; Motor Skills; Nervous System Diseases; Neuroprotection; Neuroprotective Agents; Potassium Channels; Quality of Life; Rats; Seizures | 2020 |
The underlying mechanisms of lorlatinib penetration across the blood-brain barrier and the distribution characteristics of lorlatinib in the brain.
Topics: Aminopyridines; Animals; Biological Transport; Blood-Brain Barrier; Cell Membrane Permeability; Humans; Hypoxia; Ischemia; Lactams; Lactams, Macrocyclic; Male; Neuroblastoma; Pyrazoles; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tissue Distribution; Tumor Cells, Cultured | 2020 |
PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma.
Topics: Aminopyridines; Benzamides; Drug Resistance, Neoplasm; Focal Adhesion Kinase 1; Focal Adhesion Kinase 2; Humans; Hypoxia; Multiple Myeloma; Proteasome Inhibitors; Pyrazines; Sulfonamides; Tumor Cells, Cultured | 2019 |
Role of Kv7 channels in responses of the pulmonary circulation to hypoxia.
Topics: Aminopyridines; Analgesics; Animals; Gene Expression Regulation; Hypertension, Pulmonary; Hypoxia; Indoles; KCNQ Potassium Channels; Lung; Male; Membrane Potentials; Muscle, Smooth; Potassium Channel Blockers; Pulmonary Artery; Pulmonary Circulation; Pyridines; Rats; Rats, Wistar; Vascular Resistance | 2015 |
Flupirtine effectively prevents development of acute neonatal seizures in an animal model of global hypoxia.
Topics: Acute Disease; Aminopyridines; Animals; Animals, Newborn; Anticonvulsants; Female; Hypoxia; KCNQ Potassium Channels; Male; Rats, Sprague-Dawley; Seizures | 2015 |
Effects of roflumilast, a phosphodiesterase-4 inhibitor, on hypoxia- and monocrotaline-induced pulmonary hypertension in rats.
Topics: Aminopyridines; Animals; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Hypertension, Pulmonary; Hypoxia; Male; Monocrotaline; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Rats; Rats, Wistar | 2009 |
Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension.
Topics: Aminopyridines; Animals; Disease Models, Animal; Female; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Mice; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium Channels, Voltage-Gated; Pulmonary Artery; Serotonin Plasma Membrane Transport Proteins | 2009 |
Cholinergic drugs and 4-aminopyridine alter hypoxic-induced behavioral deficits.
Topics: 4-Aminopyridine; Aminopyridines; Animals; Arecoline; Atropine; Behavior, Animal; Cholinesterase Inhibitors; Drug Interactions; Hexamethonium; Hexamethonium Compounds; Hypoxia; Male; Mecamylamine; Mice; Motor Activity; Nicotine; Parasympathomimetics; Physostigmine; Structure-Activity Relationship | 1983 |
Presynaptic neurotransmitter and chemosensory responses to natural stimuli.
Topics: 4-Aminopyridine; Aminopyridines; Animals; Atropine; Carbon Dioxide; Carotid Body; Cats; Chemoreceptor Cells; Female; Hypercapnia; Hypoxia; Injections, Intra-Arterial; Injections, Intravenous; Neurotransmitter Agents; Oxygen; Partial Pressure; Respiration; Synapses | 1984 |
3,4-diaminopyridine alters acetylcholine metabolism and behavior during hypoxia.
Topics: 4-Aminopyridine; Acetylcholine; Amifampridine; Aminopyridines; Animals; Behavior, Animal; Brain; Calcium; Glucose; Homeostasis; Hypoxia; Ion Channels; Male; Mice; Oxygen; Potassium | 1982 |
Angiotensin is not required for hypoxic constriction in salt solution-perfused rat lungs.
Topics: 4-Aminopyridine; Aminopyridines; Analysis of Variance; Angiotensin II; Animals; Hypoxia; Male; Perfusion; Potassium Chloride; Pulmonary Circulation; Rats; Rats, Inbred Strains; Sodium Chloride; Vanadates; Vanadium; Vasoconstriction | 1984 |
Pulmonary vascular effects of amrinone in conscious lambs.
Topics: Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Female; Hypoxia; Male; Propranolol; Pulmonary Circulation; Sheep; Vascular Resistance; Vasodilation | 1983 |
Synaptosomal calcium metabolism during hypoxia and 3,4-diaminopyridine treatment.
Topics: 4-Aminopyridine; Amifampridine; Aminopyridines; Animals; Calcium; Hypoxia; Male; Mice; Synaptosomes | 1984 |
Hypoxic changes in hippocampal neurons.
Topics: 4-Aminopyridine; Adenosine Triphosphate; Aminopyridines; Animals; Apamin; Caffeine; Calcium; Egtazic Acid; Electric Stimulation; Hippocampus; Hypoxia; Membrane Potentials; Neuroglia; Neuromuscular Depolarizing Agents; Neurons; Nitrogen; Quinine; Rats; Rats, Inbred Strains; Tetraethylammonium; Tetraethylammonium Compounds; Time Factors; Tolbutamide | 1989 |
Differential alteration of dopamine, acetylcholine, and glutamate release during anoxia and/or 3,4-diaminopyridine treatment.
Topics: 4-Aminopyridine; Acetylcholine; Amifampridine; Aminopyridines; Animals; Calcium; Corpus Striatum; Dopamine; Glutamates; Glutamic Acid; Hypoxia; In Vitro Techniques; Male; Mice; Potassium | 1987 |
Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Amrinone; Animals; Calcium; Cardiotonic Agents; Cats; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Humans; Hypoxia; Milrinone; Myocardial Contraction; Oxygen; Pyridones; Ranidae; Rats; Sarcoplasmic Reticulum; Stimulation, Chemical; Temperature; Time Factors | 1986 |